| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 6 |
| 1 | AMLODIPINE BESYLATE | 4 |
| 2 | CICLESONIDE | 4 |
| 3 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 4 |
| 4 | MONTELUKAST SODIUM | 4 |
| 5 | ACETAMINOPHEN | 3 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 3 |
| 7 | CALCIUM | 3 |
| 8 | EVEROLIMUS | 3 |
| 9 | EVEROLIMUS TABLETS | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 1 | ALBENDAZOLE | 2 | 0.0011 |
| 2 | ISOFLURANE | 1 | 0.0005 |
| 3 | TREOSULFAN | 1 | 0.0004 |
| 4 | CICLESONIDE | 4 | 0.0003 |
| 5 | BRENTUXIMAB VEDOTIN | 2 | 0.0002 |
| 6 | EVEROLIMUS TABLETS | 3 | 0.0002 |
| 7 | EXEMESTANE | 3 | 0.0001 |
| 8 | AZTREONAM | 1 | 0.0001 |
| 9 | DACARBAZINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 9 |
| 1 | Kinase Inhibitor [EPC] | 4 |
| 2 | mTOR Inhibitor Immunosuppressant [EPC] | 4 |
| 3 | Aromatase Inhibitor [EPC] | 3 |
| 4 | Calcium [EPC] | 3 |
| 5 | Estrogen Receptor Antagonist [EPC] | 3 |
| 6 | Expectorant [EPC] | 3 |
| 7 | Anthelmintic [EPC] | 2 |
| 8 | CD30-directed Immunoconjugate [EPC] | 2 |
| 9 | Integrin Receptor Antagonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Anthelmintic [EPC] | 2 | 0.0007 |
| 2 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 3 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Intestinal Lipase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Alkaloid [EPC] | 1 | 0.0000 |